Description

▪ Introduction

Cardarine (GW501516) is a peroxisome proliferator-activated receptor delta (PPARδ) agonist widely studied in scientific environments for its role in modulating metabolic and oxidative pathways. Its application in laboratory settings includes research into lipid metabolism, glucose homeostasis, and mitochondrial biogenesis.

▪ Product Details

• Active Ingredient: GW501516 (Cardarine)

• Dosage Strength: 20 mg

• Form: Oral Tablets

• Brand: Viogen Pharmaceuticals

• Package Size: 50 Tablets

• Intended Use: Laboratory and analytical use only

▪ Pharmacokinetics

Cardarine is orally bioavailable with a relatively long elimination half-life, approximately 16–24 hours in animal studies. It binds to PPARδ receptors, influencing gene expression related to fatty acid oxidation and energy expenditure. It is metabolized hepatically and primarily eliminated via the biliary route.

▪ Usage Recommendations

In analytical laboratory settings, Cardarine is typically dosed orally in experimental models. Tablets should be handled under controlled lab conditions using proper PPE. Storage in a cool, dry, and secure facility is recommended. All analytical protocols must follow institutional safety guidelines.

▪ Disclaimer

This product is intended strictly for laboratory research and analytical use. Not approved for human use or medical treatment. Not suitable for individuals under 18, pregnant or breastfeeding women, or those with health conditions. Must be handled by qualified professionals per local regulatory standards.